Guaifenesin And Pseudoephedrine Hcl Tablet, Extended Release
Product Images NDC 62207-827

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Pseudoephedrine Hcl (NDC 62207-827). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1200-120-mg-carton (1200 120 mg Carton)

Packaging label for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets, maximum strength, 1200 mg and 120 mg dosage. The bottle contains 70 tablets (7 bottles of 10 tablets each). It is labeled as an expectorant and nasal decongestant with 12-hour extended release, manufactured by Granules India Ltd. The label includes drug facts, directions, warnings, and inactive ingredients, along with a barcode and NDC 62207-828-71.*

FDA Label Image

1200-120-mg-foil (1200 120 mg Foi)

This is a sheet of carton labels for Guaifenesin and Pseudoephedrine HCl Extended-Release Tablet, 1200 mg and 120 mg strength. Each label indicates the product as an expectorant and nasal decongestant, manufactured by Granules India Limited, made in India. The labels instruct users to push the tablet through foil and have spaces for lot number and expiration date.*

FDA Label Image

600-60-mg-carton (600 60 mg Carton)

Packaging label for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets, 600 mg and 60 mg strength. The label indicates the product is an expectorant and nasal decongestant, with 90 tablets (9x10) in the package. Labeler is Granules India Ltd. Drug facts panels with active ingredients, uses, warnings, and other drug information are visible. The package highlights 12-hour extended release.*

FDA Label Image

600-60-mg-foil (600 60 mg Foi)

Blister pack label for Guaifenesin and Pseudoephedrine HCl Extended-Release Tablets, each containing 600 mg of Guaifenesin and 60 mg of Pseudoephedrine HCl. The label states the product is an expectorant and nasal decongestant, manufactured by Granules India Limited in India. It includes instructions to push the tablet through the foil, with space for lot number and expiration date information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.